The Olfactory Receptor Family 2, Subfamily T, Member 6 (OR2T6) Is Involved in Breast Cancer Progression via Initiating Epithelial-Mesenchymal Transition and MAPK/ERK Pathway.

Li, Ming; Wang, Xiao; Ma, Ran-Ran; Shi, Duan-Bo; Wang, Ya-Wen; Li, Xiao-Mei; He, Jun-Yi; Wang, Jun; Gao, Peng

Li, Ming; Wang, Xiao; Ma, Ran-Ran; Shi, Duan-Bo; Wang, Ya-Wen; Li, Xiao-Mei; He, Jun-Yi; Wang, Jun; Gao, Peng.

Afiliación

Li M; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Medicine, Shandong University, Jinan, China.
Wang X; Department of Pathology, Dezhou People's Hospital, Dezhou, China.
Ma RR; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Medicine, Shandong University, Jinan, China.
Shi DB; Department of Pathology, Qilu Hospital, Shandong University, Jinan, China.
Wang YW; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Medicine, Shandong University, Jinan, China.
Li XM; Department of Pathology, Qilu Hospital, Shandong University, Jinan, China.
He JY; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Medicine, Shandong University, Jinan, China.
Wang J; Department of Pathology, Qilu Hospital, Shandong University, Jinan, China.
Gao P; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Medicine, Shandong University, Jinan, China.

Front Oncol ; 9: 1210, 2019.

Article en En | MEDLINE | ID: mdl-31781505

Palabras clave

MAPK/ERK pathway; OR2T6; breast carcinoma; epithelial-mesenchymal transition; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article País de afiliación: China